GlaxoSmithKline and Pfizer will hold out for a better bid of at least £60 billion for their joint consumer healthcare venture, in opposition to an...
Pfizer and Moderna could make billions of dollars from COVID-19 booster shots, earnings comparable to the $6 billion generated each year in flu vaccine sales....
The first doses of the Pfizer-BioNTech COVID-19 vaccine, outside of clinical trials, started being administered to healthcare workers and nursing home staffers on Monday (Dec.14)....
Dr. Moncef Slaoui, who acts as President Donald Trump’s COVID-19 vaccine czar, said the U.S. should have enough vaccines to immunize 100 million people by...
With COVID-19’s worldwide case count officially exceeding 11 million and waves of closures sweeping U.S. states in an attempt to stifle the resurgent threat, an...
As other stocks rebounded at the news of a breakthrough in Pfizer and BioNTech’s joint COVID-19 vaccine, bitcoin fell sharply to nearly $14,815, according to...